Prospective, Single Arm, Observational Study of Faricimab in the Treatment of Neovascular Age-related Macular Degeneration (nAMD)
Clinical trial NCT07581782 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07581782
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-05-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.